Showing results (51-60 of 127) with videos related to
Sort By:
Pageof 13
Pharmaceutical Science Advances|March 30, 2026
Unleashing the power of DNA-encoded libraries for challenging targets in drug discoveryNana Du, Yijun Li, Qing Lou, et al.Pharmaceutical Science Advances|April 20, 2026
Functional identification of key enzymes in calycosin biosynthesis in Astragalus membranaceus and establishment of heterologous expression systemMing-Xin Cui, Yue Hao, Jiang-Nan Li, et al.Pharmaceutical Science Advances|June 3, 2026
Discovery of novel Kir4.1 inhibitors based on serdemetan with potential therapy for glioblastoma-depression comorbidityHao Gu, Sisi Wang, Mengdan Li, et al.Pharmaceutical Science Advances|August 9, 2026
The gut-lung axis and viral pneumonia: Unrevealing the gut microbiotaShiqing Zhuo, Liting Fu, Xiaofei Chen, et al.Pharmaceutical Science Advances|August 8, 2026
Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPDXiaobing Wang, Xiaoxi Xu, Chunlei Cheng, et al.Pharmaceutical Science Advances|September 12, 2026
In vivo immune cell engineering from bench to clinical realityHui Yu, Maosen Han, Xiaotian Zhao, et al.Pharmaceutical Science Advances|September 17, 2026
The substrate envelope strategy: Structural basis for resistance mitigation in antiviral drug designQiaojie Xu, Jiwei Zhang, Yanxu Hou, et al.Pharmaceutical Science Advances|October 13, 2026
Corrigendum to "Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib" [Pharmaceut. Sci. Adv. 4, (2026), 100125]Fuxun Huang, Peng Zhan, Xiujuan Shi, et al.Pharmaceutical Science Advances|May 21, 2026
Pharmaceutical development of composition of effervescent tablets with acetylsalicylic acid, paracetamol, and ascorbic acidOksana PanyshevaPharmaceutical Science Advances|June 8, 2026
Therapeutic potential of the sphingosine kinase 2 inhibitor opaganibFuxun Huang, Peng Zhan, Xiujuan Shi, et al.Pageof 13